UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients-Reference-Cited by-同舟云学术

UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients

Published:2018-01 Issue: Volume:1073 Page:183-190
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Notari Stefania,Tempestilli Massimo,Fabbri Gabriele,Libertone Raffaella,Antinori Andrea,Ammassari Adriana,Agrati Chiara

Funder

Italian Ministry of Health Ricerca Corrente

SIMIT scholarship 2016

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference30 articles.

1. Hepatitis C: Fact Sheet Updated July 2016;World Health Organization,2016

2. EASL clinical practice guidelines: management of hepatitis C virus infection;European Association for Study of L;J. Hepatol.,2014

3. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents;Poordad;J. Viral Hepat.,2012

4. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N. Engl. J. Med.,2013

5. Hepatitis C cirrhosis: new perspectives for diagnosis and treatment;Khullar;World J. Hepathol.,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A natural hydrophobic deep eutectic solvent-based microextraction method integrated with a spectrofluorimetric technique for the determination of daclatasvir as a direct-acting hepatitis C antiviral drug in plasma samples;Microchemical Journal;2023-09

2. Development and validation of LC–MS/MS methods for the simultaneous quantification of sofosbuvir and its major metabolite (GS‐331007) in blood plasma and cerebrospinal and seminal fluid: Application to a pilot clinical trial with a focus on Zika;Biomedical Chromatography;2023-03-05

3. Analytical approaches for determination of COVID-19 candidate drugs in human biological matrices;TrAC Trends in Analytical Chemistry;2023-03

4. STABILITY INDICATING HPLC METHOD FOR SOFOSBUVIR AND DACLATASVIR IN COMBINATION;Indian Drugs;2022-11-14

5. Utilizing Sucrose-Functionalized Gold Nanoparticles for Daclatasvir: Chemometric Optimization and Determination;Plasmonics;2022-07-01